Brief: Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase
23/07/2025 13:39
July 23 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O: ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILING ORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILING Source text: [ID:n0001213900-25-066819] Further company coverage: ORMP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results